EvogeneEVGN +2.00%33 Days Inventory is 0.00 as of Mar. 2026. GuruFocus rates EVGN with a GF Score™ of 33/100 and a GF Value™ of $0.40 (Fairly Valued). The stock has 7 warning signs investors should review. Among 635 Biotechnology companies, Evogene ranks better than 66.61% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Evogene's Average Total Inventories for the
three
months ended in Mar. 2026 was $0.19 Mil. Evogene's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $0.00 Mil.
The historical rank and industry rank for Evogene's Days Inventory or its related term are showing as below:
EVGN'
s Days Inventory Range Over the Past 10 Years
Min: 43.8 Med: 90.45 Max: 145.34
Current: 117.73
During the past 13 years, Evogene's highest Days Inventory was 145.34. The lowest was 43.80. And the median was 90.45.
EVGN's Days Inventory is ranked better than 66.61% of 635
companies
in the Biotechnology industry
Industry Median: 183.23
vs EVGN: 117.73
Evogene's Days Inventory
declined
from Mar. 2025 (112.25) to Mar. 2026 (0.00).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Evogene's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Evogene (NAS:EVGN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Evogene's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Evogene's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Evogene Days Inventory Related Terms
Evogene Days Inventory Historical Data
* Premium members only.
The historical data trend for Evogene's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVGN vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Evogene's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evogene Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Evogene's Days Inventory distribution charts can be found below:
* The bar in red indicates where Evogene's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evogene (EVGN) has a Days Inventory of 0.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Evogene and its competitors. Over the past decade, Evogene's Days Inventory has ranged from 43.80 to 145.34. According to the industry distribution chart, Evogene ranks #212 out of 635 companies in the Biotechnology industry, placing it in the top 33.4%.
Is Evogene's Days Inventory too high?
Evogene's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 43.80 to a high of 145.34. Based on the distribution chart, Evogene ranks #212 out of 635 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Evogene has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evogene's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Evogene ranks #212 out of 635 companies for Days Inventory. This puts Evogene in the upper half of its industry. The industry median Days Inventory is 183.23. Historically, Evogene's own Days Inventory has ranged from 43.80 to 145.34 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Evogene and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evogene's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evogene stock overvalued right now?
Based on GuruFocus' analysis, Evogene (EVGN) is currently considered Fairly Valued. The stock's GF Value™ is $0.40, compared to a current price of $0.44 — trading 9.6% above its estimated fair value. The current Days Inventory is 0.00. Evogene's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Evogene (EVGN), the current Days Inventory is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evogene (EVGN) Overvalued in 2026?
Based on GuruFocus' analysis, Evogene stock appears to be overvalued.
The current stock price of $0.44 is trading 9.6% above its estimated GF Value™ of $0.40.
GuruFocus considers Evogene to be Fairly Valued.
Key valuation signals for EVGN:
Days Inventory: 0.00
GF Value™: $0.40 vs. price of $0.44 (9.6% above fair value)
No single metric tells the full story. See the EVGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
33GF Score
Get the complete analysis for EVGN
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVGN has been successfully added to your 
